首页 | 本学科首页   官方微博 | 高级检索  
检索        

复方蛹虫草制剂对C57BL/6荷瘤小鼠免疫功能的影响
引用本文:季锡中,宁青,谈唯,张润桐,宋捷.复方蛹虫草制剂对C57BL/6荷瘤小鼠免疫功能的影响[J].中国实验方剂学杂志,2012,18(15):227-230.
作者姓名:季锡中  宁青  谈唯  张润桐  宋捷
作者单位:江苏省中医药研究院中药新型给药系统重点实验室/国家中医药管理局中药口服释药系统重点研究室,南京,210028
摘    要:目的:研究蛹虫草复方制剂(CCM)对C57BL/6荷瘤小鼠免疫功能影响.方法:C57 BL/6雄性小鼠腋下皮下注入Lewis肺癌小鼠移植瘤动物模型,将荷瘤鼠分为模型组、阳性对照组以环磷酰胺ip 20 mg· kg-,复方蛹虫草制剂低、中、高剂量组(1.2,2.5,7.5)g·kg-1ig给药,连续给药14 d,以抑瘤率为指标考察CCM的体内抗肿瘤活性,分别测定其抑瘤率、T淋巴细胞亚群CD4 +/CD8+;荷瘤小鼠血清中白细胞介素-2(IL-2)、白细胞介素-12(IL-12)、肿瘤坏死因子-α(TNF-α)水平;抗体生成细胞数以及力竭游泳时间.结果:CCM高剂量组(7.5 g·kg-1对肿瘤生长有明显的抑制作用(P<0.05),其抑瘤率为40.3%,CCM高剂量组T淋巴细胞亚群CD3+,CD4+,CD4+/CD8+均高于模型对照组;同时中、高剂量组能显著提高荷瘤小鼠血清TNF-α,IL-2,IL-12的水平;抗体生成细胞数和力竭游泳时间也均高于荷瘤对照组(P<0.05).结论:CCM具有提高荷瘤小鼠免疫功能的作用.

关 键 词:蛹虫草  荷瘤小鼠  抗肿瘤  免疫调节
收稿时间:2011/8/28 0:00:00

Effects of Compound Cordyceps militaris on Immune Function in C57BL/6 Tumor Bearing Mice
JI Xi-zhong,NING Qing,TAN Wei,ZHANG Run-tong and SONG Jie.Effects of Compound Cordyceps militaris on Immune Function in C57BL/6 Tumor Bearing Mice[J].China Journal of Experimental Traditional Medical Formulae,2012,18(15):227-230.
Authors:JI Xi-zhong  NING Qing  TAN Wei  ZHANG Run-tong and SONG Jie
Institution:Key Laboratory of New Drug Delivery System of Chinese Meteria Medica, Jiangsu Provincial Academy of Chinese Medicine, Key Laboratory of Drug Release System of Oral Traditional Chinese Mealicine(TCM), State Administration of TCM, Nanjing 210028, China;Key Laboratory of New Drug Delivery System of Chinese Meteria Medica, Jiangsu Provincial Academy of Chinese Medicine, Key Laboratory of Drug Release System of Oral Traditional Chinese Mealicine(TCM), State Administration of TCM, Nanjing 210028, China;Key Laboratory of New Drug Delivery System of Chinese Meteria Medica, Jiangsu Provincial Academy of Chinese Medicine, Key Laboratory of Drug Release System of Oral Traditional Chinese Mealicine(TCM), State Administration of TCM, Nanjing 210028, China;Key Laboratory of New Drug Delivery System of Chinese Meteria Medica, Jiangsu Provincial Academy of Chinese Medicine, Key Laboratory of Drug Release System of Oral Traditional Chinese Mealicine(TCM), State Administration of TCM, Nanjing 210028, China;Key Laboratory of New Drug Delivery System of Chinese Meteria Medica, Jiangsu Provincial Academy of Chinese Medicine, Key Laboratory of Drug Release System of Oral Traditional Chinese Mealicine(TCM), State Administration of TCM, Nanjing 210028, China
Abstract:Objective: To study the effects of compoun Dcordyceps militaris(CCM) on immune function in C57BL/6 tumor bearing mice.Method: Transplanted Lewis tumor mice were established using subcutaneous injection of Lewis cells into C57BL/6 mice.C57BL/6 tumor bearing mice were randomly divided into five groups,namely,control group and positive group(cyclophosphamide ip 20 mg·kg-1),the low,middle and high dosage groups(ig 1.2,2.5,7.5 g·kg-1) for 14 constitutive days.The tumor inhibition rate,CD4+/CD8+ ratio,contents of interleukin(IL)-2,IL-12 and tumor necrosis factor-α(TNF-α) in tumor bearing mice serum,antibody-producing cells and forced swimming time were respectively determined.Result: CCM(7.5 g·kg-1),orally administered,had a significant inhibitory action on the growth of tumor,with the inhibition rate as 40.3%(P<0.05).CCM(7.5 g·kg-1) also improved CD3+,CD4+,CD4+/CD8+ ratio compared with the control group.Meanwhile,CCM(2.5,7.5 g·kg-1) enhanced the content of IL-2,IL-12 and TNF-α level,forced swimming time and antibody-producing cells(P<0.05).Conclusion: These findings suggested that CCM could promote the function of immunity in C57BL/6 tumor bearing mice.
Keywords:Cordyceps militaris  tumor bearing mice  anti-tumor  immunoregulation
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号